fluoxetine and nortriptyline

fluoxetine has been researched along with nortriptyline in 129 studies

Research

Studies (129)

Timeframe	Studies, this research(%)	All Research%
pre-1990	7 (5.43)	18.7374
1990's	31 (24.03)	18.2507
2000's	62 (48.06)	29.6817
2010's	29 (22.48)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Dukat, M; Glennon, RA; Hufeisen, S; Lee, DK; Lee, M; McBride, A; Rangisetty, JB; Rauser, L; Roth, BL; Savage, JE	1
Topliss, JG; Yoshida, F	1
Dansette, PM; Fontana, E; Poli, SM	1
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL	1
Goetz, RM; Karpowich, NK; Law, CJ; Reith, ME; Wang, DN; Zhen, J; Zhou, Z	1
Bergström, F; Giordanetto, F; Rehngren, M; Tunek, A; Wan, H	1
Bleich, S; Gulbins, E; Kornhuber, J; Reichel, M; Terfloth, L; Tripal, P; Wiltfang, J	1
Ahman, M; Holmén, AG; Wan, H	1
Aharoni, A; Geffen, Y; Gil-Ad, I; Halbfinger, E; Nisemblat, Y; Nudelman, A; Rephaeli, A; Tarasenko, I; Tarasenko, N; Weizman, A	1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A	1
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM	1
García-Mera, X; González-Díaz, H; Prado-Prado, FJ	1
Glen, RC; Lowe, R; Mitchell, JB	1
Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ	1
Boriss, H; Braggio, S; Corbioli, S; Fontana, S; Helmdach, L; Longhi, R; Schiller, J; Vinco, F	1
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V	1
Freiwald, S; Jiang, Y; Jones, JP; Kaspera, R; Katayama, J; Lee, CA; Smith, E; Totah, RA; Walker, GS	1
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ	1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Jones, LH; Nadanaciva, S; Rana, P; Will, Y	1
Jones, GT; Moore, RA; Slater, IH	1
Bergmann, K; Bindman, J; Jennings, AL; Phillips, J; Seth, R	1
Brown, WA; Daamen, MJ	1
Brockmöller, J; Müller, N; Roots, I	1
Nierenberg, AA	1
Extein, IL	1
Fabre, LF; Itil, TM; Scharf, MB	1
Barrow, NE; Crismon, ML; Michals, M; Stanley, DA	1
Fedoroff, JP; Morris, PL; Robinson, RG	1
Epstein, S; Gutierrez, MA; Skowron, DM	1
Kahn, DG	1
von Ammon Cavanaugh, S	1
Breitner, JC; Figiel, GS; Krishnan, KR; Nemeroff, CB	1
Benedetti, G; Clayton, A; Hoyle, K; Schraml, F	1
Eckert, ED; Hatsukami, D; Mitchell, JE; Pomeroy, C; Pyle, RL; Zimmerman, R	1
Hrdina, PD	1
Bhargava, AK; Hudecki, MS; Hudecki, RS; Pollina, CM	1
Brambilla, F; Brunetta, M; Draisci, A; Peirone, A	1
Chaleby, K; el-Yazigi, A; Gad, A; Raines, DA	1
Flint, AJ; Rifat, SL	4
Bianchi, M; Panerai, AE; Sacerdote, P	1
Attia, E; Glassman, AH; Roose, SP; Woodring, S	1
el-Yazigi, A; Raines, DA	1
Stokes, PE	1
Gillman, PK	2
Hambrecht, M	1
Brambilla, F; Brunetta, M; Manfredi, B; Panerai, AE; Peirone, A; Perna, G; Sacerdote, P	1
De Meester, I; Desnyder, R; Maes, M; Meltzer, HY; Ranjan, R; Scharpe, S	1
Byrne, S; Rothschild, AJ	1
Almeida, OP; Tamai, S	1
Benazzi, F	1
Attia, E; Bigger, JT; Giardina, EG; Glassman, AH; Roose, SP; Woodring, S	1
Roose, SP; Suthers, KM	1
Meyers, BS	1
Erenmemisoglu, A; Ozdogan, UK; Saraymen, R; Tutus, A	1
Bolanos, S; Bytautiene, E; Fulep, E; Garfield, RE; Saade, GR; Vedernikov, Y	1
Castillo, C; Curdue, K; Kopel, T; Kosier, JT; Newman, RM; Petracca, G; Robinson, RG; Schultz, SK; Starkstein, SE	1
Anthony, JP; Neumaier, JF; Sexton, TJ	1
Hatsuda, S; Hayashi, T; Kimura, H; Matsubara, M; Miura, K; Mori, T; Murakami, H; Ohara, M; Ohta, T; Sugita, S; Suzuki, S; Terashima, M	1
Gendall, KA; Joyce, PR; Mulder, RT; Sullivan, PF	1
Franco, K; Malhotra, S	1
Clary, CM; Doraiswamy, PM; Krishnan, KR	1
Baba, J; Fujishiro, J; Imanishi, T; Kosaka, K	1
Joyce, PR; Luty, SE; Mulder, RT	2
Kosier, JT; Narushima, K; Robinson, RG	1
Abbott, RM; Joyce, PR; Luty, SE; McKenzie, JM; Mulder, RT; Stevens, IF; Sullivan, PF	2
Begg, EJ; Joyce, PR; Kennedy, MA; Mulder, RT; Roberts, RL	1
Joyce, PR; Luty, SE; McKenzie, JM; Mulder, RT; Rae, AM	1
Joyce, PR; Kennedy, MA; Luty, SE; Miller, AL; Mulder, RT; Rogers, GR	1
Frampton, C; Joyce, PR; Mulder, RT	1
Joyce, PR; Luty, SE; Mulder, RT; Watkins, WG	1
Arndt, S; Jorge, RE; Robinson, RG; Starkstein, S	1
Murray, K; Murray, M	1
Joyce, PR; Kennedy, MA; Luty, SE; McKenzie, JM; Miller, AL; Mulder, RT; Rogers, GR	1
Afkham, K; Akhondzadeh, S; Fakhrzadeh, H; Faraji, H; Kamalipour, A; Sadeghi, M	1
Burt, T; Clary, CM; Coffey, DJ; Doraiswamy, PM; Jenkyn, LR; Krishnan, KR; Oxman, T	1
Joyce, PR; Kennedy, MA; Luty, SE; Mulder, RT; Roberts, RL	1
Gendall, KA; Joyce, PR; Luty, SE; Mulder, RT	1
Cloninger, CR; Joyce, PR; Luty, SE; McKenzie, JM; Mulder, RT	1
Bulik, CM; Carter, FA; Joyce, PR; Luty, SE; McIntosh, VV; McKenzie, JM; Mulder, RT; Sullivan, PF	1
Dean, CE	1
Joyce, PR; Kennedy, MA; Luty, SE; McKenzie, JM; Miller, AL; Mulder, RT; Porter, RJ	1
Joyce, PR; Luty, SE; Mulder, RT; Porter, RJ	1
Nagappa, AN; Vijayapandi, P	1
Briggs, SD; Case, M; Corya, SA; Sanger, TM; Shelton, RC; Tollefson, GD; Van Campen, LE; Williamson, DJ	1
Joyce, PR; Kennedy, MA; Luty, SE; McKenzie, JM; Miller, AL; Mulder, RT; Sullivan, PF	1
Lavori, PW; Roose, SP; Sackeim, HA	1
Ghanizadeh, A; Mowla, A; Pani, A	1
Arndt, S; Campayo, A; Chan, KL; Moser, DJ; Robinson, RG	1
Carroll, BJ; Chang, YH; Kim, DK; Kim, H; Kim, JW; Kim, S; Lim, SW	1
Jorge, R; Moser, DJ; Narushima, K; Paradiso, S; Robinson, RG	1
Guo, B; He, MM; Li, C; Liu, H; Shen, H; Wang, L; Wrighton, SA	1
Bonan, CD; de Freitas Sarkis, JJ; Pedrazza, EL; Pedrazza, L; Rico, EP; Senger, MR; Zimmermann, FF	1
Fiedorowicz, JG; Robinson, RG; Takezawa, K	1
Bogo, MR; Bonan, CD; Pedrazza, EL; Pedrazza, L; Rico, EP; Sarkis, JJ; Senger, MR; Zimmermann, FF	1
Frampton, CM; Joyce, PR; Luty, SE; Mulder, RT	2
Ayers, DM; Durieux, ME; Johannes, T; Ploppa, A; Unertl, KE	1
Billups, SJ; Delate, T; Dugan, D	1
Furutani, K; Hibino, H; Inanobe, A; Kurachi, Y; Ohno, Y	1
Campbell, GM; Case, M; Corya, SA; Henley, DB; Osuntokun, O; Thase, ME; Trivedi, MH; Watson, SB	1
Frampton, C; Harley, J; Joyce, P; Kennedy, M; Luty, S; Mulder, R; Roberts, R	1
Carter, JD; Frampton, CM; Johnstone, JM; Joyce, PR; Luty, SE; Mulder, RT	1
Frampton, CM; Joyce, PR; Mulder, RT	1
Deng, X; Joyce, PR; Kennedy, MA; McHugh, PC	1
Carter, JD; Joyce, PR; Luty, SE; McKenzie, JM; Mulder, RT; Pearson, JF; Spittlehouse, JK	1
Adams, HP; Davis, PH; Jang, M; Jorge, RE; Leira, EC; Mikami, K; Robinson, RG	1
Helsel, JC; Luther, JF; Perel, JM; Sit, D; Wisner, KL; Wisniewski, SR	1
Furutani, K; Inanobe, A; Kurachi, Y; Ohno, Y; Yamakawa, Y	1
Cabral, A; Ferreira, LS; Izídio, GS; Macedo, PT; Melo, TG; Ribeiro, AM; Silva, RH; Sousa, DS	1
Chua, EW; Foulds, J; Kennedy, MA; Miller, AL	1
Howard, LM; Karia, AM; McGeown, HR; Molyneaux, E; Trevillion, K	1
Barbui, C; Cipriani, A; Furukawa, TA; Hayasaka, Y; Leucht, S; Magni, LR; Ogawa, Y; Purgato, M; Takeshima, N	1
Asth, L; Calo', G; Gavioli, EC; Guerrini, R; Holanda, VA; Medeiros, IU	1
Cipriani, A; Coghill, D; Cohen, D; Cuijpers, P; Del Giovane, C; Hazell, P; Hetrick, SE; Leucht, S; Liu, L; Liu, Y; Michael, KD; Pu, J; Qin, B; Ravindran, AV; Whittington, C; Xie, P; Yang, L; Zhang, Y; Zhou, X	1
Abreu, MS; Barcellos, LJ; Bogo, MR; Conterato, GM; Herrmann, AP; Kist, LW; Koakoski, G; Marcon, M; Mocelin, R; Piato, AL; Rambo, CL; Zanatta, L	1
Alves, JSF; Asth, L; Ayres, ASFSJ; Castellanos, L; Costa, GM; Gavioli, EC; Junqueira-Ayres, DD; Medeiros, IU; Ramos, FA; Santos, WB; Zucolotto, SM	1
Asth, L; Calo', G; Gavioli, EC; Guerrini, R; Holanda, VAD; Ruzza, C; Santos, WB	1
Arnold, PD; Bousman, C; Greenslade, A; Maruf, AA	1
Gneushev, ET; Kondratenko, SN; Kukes, VG; Savelyeva, MI; Shikh, EV	1
Alsaab, S; Cobb, C; Haidari, M; Mansani, S; Ponds, D; Romero, L	1

Reviews

9 review(s) available for fluoxetine and nortriptyline

Article	Year
Cytochrome p450 enzymes mechanism based inhibitors: common sub-structures and reactivity. Current drug metabolism, 2005, Volume: 6, Issue:5 Topics: Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Drug Interactions; Enzyme Inhibitors; Humans; Isoenzymes; Structure-Activity Relationship; Terminology as Topic	2005
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016
Depression and cerebrovascular disease. The Journal of clinical psychiatry, 1990, Volume: 51 Suppl Topics: Cerebrovascular Disorders; Depressive Disorder; Desipramine; Female; Fluoxetine; Humans; Male; Nortriptyline	1990
A primary care perspective on management of acute and long-term depression. The Journal of clinical psychiatry, 1993, Volume: 54 Suppl Topics: Acute Disease; Adult; Aged; Depressive Disorder; Drug Administration Schedule; Drug Therapy, Combination; Family Practice; Female; Fluoxetine; Humans; Male; Middle Aged; Nortriptyline; Patient Compliance; Patient Education as Topic; Psychiatry; Recurrence; Referral and Consultation; Selective Serotonin Reuptake Inhibitors	1993
Antidepressant response in late-life depression. The Journal of clinical psychiatry, 1998, Volume: 59 Suppl 10 Topics: 1-Naphthylamine; Age Factors; Aged; Antidepressive Agents, Tricyclic; Clinical Trials as Topic; Depressive Disorder; Drug Administration Schedule; Fluoxetine; Humans; Middle Aged; Nortriptyline; Paroxetine; Patient Dropouts; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome	1998
Depression and dementia: comorbidities, identification, and treatment. Journal of geriatric psychiatry and neurology, 1998,Winter, Volume: 11, Issue:4 Topics: Aged; Aged, 80 and over; Antidepressive Agents, Tricyclic; Benzamides; Citalopram; Clomipramine; Cognition Disorders; Comorbidity; Dementia; Depression; Female; Fluoxetine; Fluvoxamine; Humans; Imipramine; Male; Middle Aged; Moclobemide; Monoamine Oxidase Inhibitors; Neuropsychological Tests; Nortriptyline; Selective Serotonin Reuptake Inhibitors; Sertraline	1998
Antidepressant treatment for postnatal depression. The Cochrane database of systematic reviews, 2014, Sep-11, Issue:9 Topics: Adult; Antidepressive Agents, Second-Generation; Clinical Trials as Topic; Depression, Postpartum; Female; Fluoxetine; Humans; Nortriptyline; Paroxetine; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Sertraline	2014
Comparative efficacy and tolerability of antidepressants for major depressive disorder in children and adolescents: a network meta-analysis. Lancet (London, England), 2016, Aug-27, Volume: 388, Issue:10047 Topics: Adolescent; Amitriptyline; Antidepressive Agents; Bayes Theorem; Child; Citalopram; Clomipramine; Confounding Factors, Epidemiologic; Depressive Disorder, Major; Desipramine; Double-Blind Method; Drug Administration Schedule; Duloxetine Hydrochloride; Evidence-Based Medicine; Fluoxetine; Humans; Imipramine; Mianserin; Mirtazapine; Nortriptyline; Paroxetine; Piperazines; Randomized Controlled Trials as Topic; Research Design; Sertraline; Treatment Outcome; Triazoles; Venlafaxine Hydrochloride	2016
Antidepressant pharmacogenetics in children and young adults: A systematic review. Journal of affective disorders, 2019, 07-01, Volume: 254 Topics: Adolescent; Amitriptyline; Antidepressive Agents; Child; Citalopram; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP2D6; Female; Fluoxetine; Fluvoxamine; Humans; Male; Mental Disorders; Nortriptyline; Paroxetine; Pharmacogenetics; Serotonin Plasma Membrane Transport Proteins; Sertraline; Tryptophan Hydroxylase; Venlafaxine Hydrochloride; Young Adult	2019

Trials

41 trial(s) available for fluoxetine and nortriptyline

Article	Year
Comparative efficacy and safety of nortriptyline and fluoxetine in the treatment of major depression: a clinical study. The Journal of clinical psychiatry, 1991, Volume: 52 Suppl Topics: Adolescent; Adult; Aged; Depressive Disorder; Drug Administration Schedule; Female; Fluoxetine; Humans; Male; Middle Aged; Nortriptyline; Patient Dropouts; Psychiatric Status Rating Scales; Severity of Illness Index	1991
Response to alternative antidepressants in imipramine nonresponders with bulimia nervosa. Journal of clinical psychopharmacology, 1989, Volume: 9, Issue:4 Topics: Adolescent; Adult; Antidepressive Agents; Bulimia; Clinical Trials as Topic; Desipramine; Feeding Behavior; Female; Fluoxetine; Humans; Imipramine; Monoamine Oxidase Inhibitors; Nortriptyline; Random Allocation	1989
Combined cognitive-behavioral, psychopharmacological and nutritional therapy in eating disorders. 1. Anorexia nervosa--restricted type. Neuropsychobiology, 1995, Volume: 32, Issue:2 Topics: Adolescent; Adult; Anorexia Nervosa; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Anxiety; Behavior Therapy; Body Weight; Cognitive Behavioral Therapy; Combined Modality Therapy; Depression; Feeding and Eating Disorders; Female; Fluoxetine; Humans; Nortriptyline; Nutritional Physiological Phenomena; Psychiatric Status Rating Scales	1995
Steady-state kinetics of fluoxetine and amitriptyline in patients treated with a combination of these drugs as compared with those treated with amitriptyline alone. Journal of clinical pharmacology, 1995, Volume: 35, Issue:1 Topics: Adolescent; Adult; Amitriptyline; Bipolar Disorder; Chromatography, High Pressure Liquid; Depression; Depressive Disorder; Drug Interactions; Drug Therapy, Combination; Female; Fluoxetine; Humans; Male; Metabolic Clearance Rate; Middle Aged; Nortriptyline	1995
Comparative efficacy of selective serotonin reuptake inhibitors and tricyclics in the treatment of melancholia. The American journal of psychiatry, 1994, Volume: 151, Issue:12 Topics: Age Factors; Aged; Comorbidity; Cross-Over Studies; Depressive Disorder; Double-Blind Method; Female; Fluoxetine; Heart Diseases; Hospitalization; Humans; Male; Middle Aged; Nortriptyline; Placebos; Psychiatric Status Rating Scales	1994
T-lymphocyte cholecystokinin-8 and beta-endorphin concentrations in eating disorders: I. Anorexia nervosa. Psychiatry research, 1995, Nov-29, Volume: 59, Issue:1-2 Topics: Adolescent; Adult; Anorexia Nervosa; Antidepressive Agents; beta-Endorphin; Child; Cognitive Behavioral Therapy; Combined Modality Therapy; Dibenzocycloheptenes; Female; Fluoxetine; Humans; Nortriptyline; Sincalide; T-Lymphocytes; Treatment Outcome	1995
Anxious depression in elderly patients. Response to antidepressant treatment. The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry, 1997,Spring, Volume: 5, Issue:2 Topics: Aged; Aged, 80 and over; Antidepressive Agents; Anxiety Disorders; Combined Modality Therapy; Depressive Disorder; Electroconvulsive Therapy; Female; Fluoxetine; Humans; Male; Middle Aged; Nortriptyline; Phenelzine; Psychiatric Status Rating Scales; Treatment Outcome	1997
Nortriptyline versus fluoxetine in the treatment of depression and in short-term recovery after stroke: a placebo-controlled, double-blind study. The American journal of psychiatry, 2000, Volume: 157, Issue:3 Topics: Activities of Daily Living; Antidepressive Agents, Tricyclic; Cognition Disorders; Depressive Disorder; Double-Blind Method; Drug Administration Schedule; Fluoxetine; Humans; Nortriptyline; Placebos; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Social Adjustment; Stroke; Stroke Rehabilitation; Treatment Outcome; Weight Loss	2000
The effects of fluoxetine versus nortriptyline on body weight in depression. Journal of clinical psychopharmacology, 2000, Volume: 20, Issue:6 Topics: Adrenergic Uptake Inhibitors; Body Weight; Female; Fluoxetine; Humans; Male; Mood Disorders; Nortriptyline; Regression Analysis; Selective Serotonin Reuptake Inhibitors	2000
Clinical and treatment response characteristics of late-life depression associated with vascular disease: a pooled analysis of two multicenter trials with sertraline. Progress in neuro-psychopharmacology & biological psychiatry, 2001, Volume: 25, Issue:2 Topics: Age of Onset; Aged; Antidepressive Agents; Anxiety; Cardiovascular Diseases; Comorbidity; Depressive Disorder; Double-Blind Method; Female; Fluoxetine; Humans; Hypertension; Male; Mental Status Schedule; Middle Aged; Nortriptyline; Patient Selection; Placebos; Psychiatric Status Rating Scales; Safety; Sertraline; Vascular Diseases	2001
Comparison between noradrenergic and serotonergic medications using the social adjustment scale: is drive enhancement necessary for recovery of social functioning? Journal of psychopharmacology (Oxford, England), 2001, Volume: 15, Issue:4 Topics: Adrenergic Agents; Adrenergic Uptake Inhibitors; Adult; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Depressive Disorder; Female; Fluoxetine; Humans; Life Style; Male; Norepinephrine; Nortriptyline; Psychiatric Status Rating Scales; Psychomotor Performance; Selective Serotonin Reuptake Inhibitors; Social Adjustment; Treatment Outcome	2001
Preventing poststroke depression: a 12-week double-blind randomized treatment trial and 21-month follow-up. The Journal of nervous and mental disease, 2002, Volume: 190, Issue:5 Topics: Adolescent; Adult; Aged; Antidepressive Agents, Tricyclic; Depressive Disorder; Double-Blind Method; Drug Administration Schedule; Female; Fluoxetine; Follow-Up Studies; Humans; Longitudinal Studies; Male; Middle Aged; Nortriptyline; Placebos; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Stroke; Substance Withdrawal Syndrome; Treatment Outcome	2002
Patterns and predictors of remission, response and recovery in major depression treated with fluoxetine or nortriptyline. The Australian and New Zealand journal of psychiatry, 2002, Volume: 36, Issue:3 Topics: Adult; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Depressive Disorder; Female; Fluoxetine; Humans; Male; Nortriptyline; Predictive Value of Tests; Psychiatric Status Rating Scales; Remission Induction; Time Factors; Treatment Outcome	2002
A common P-glycoprotein polymorphism is associated with nortriptyline-induced postural hypotension in patients treated for major depression. The pharmacogenomics journal, 2002, Volume: 2, Issue:3 Topics: Adult; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Depressive Disorder; DNA; Female; Fluoxetine; Genotype; Humans; Hypotension, Orthostatic; Male; Nortriptyline; Polymorphism, Restriction Fragment Length; Reverse Transcriptase Polymerase Chain Reaction	2002
The relationship of personality disorders to treatment outcome in depressed outpatients. The Journal of clinical psychiatry, 2003, Volume: 64, Issue:3 Topics: Adult; Age Factors; Ambulatory Care; Antidepressive Agents; Chronic Disease; Comorbidity; Depressive Disorder; Female; Fluoxetine; Humans; Male; Nortriptyline; Personality Disorders; Psychiatric Status Rating Scales; Severity of Illness Index; Social Adjustment; Treatment Outcome	2003
A differential response to nortriptyline and fluoxetine in melancholic depression: the importance of age and gender. Acta psychiatrica Scandinavica, 2003, Volume: 108, Issue:1 Topics: Adolescent; Adrenergic Uptake Inhibitors; Adult; Age Factors; Antidepressive Agents, Second-Generation; Depressive Disorder; Female; Fluoxetine; Humans; Logistic Models; Male; Nortriptyline; Odds Ratio; Psychiatric Status Rating Scales; Sex Factors	2003
Polymorphisms of DRD4 and DRD3 and risk of avoidant and obsessive personality traits and disorders. Psychiatry research, 2003, Jul-15, Volume: 119, Issue:1-2 Topics: Adult; Alleles; Character; Exons; Exploratory Behavior; Female; Fluoxetine; Genotype; Humans; Male; Nortriptyline; Obsessive-Compulsive Disorder; Personality Disorders; Polymerase Chain Reaction; Polymorphism, Genetic; Receptors, Dopamine D2; Receptors, Dopamine D3; Receptors, Dopamine D4; Risk Factors; Selective Serotonin Reuptake Inhibitors; Temperament; Trinucleotide Repeats	2003
Relationships among measures of treatment outcome in depressed patients. Journal of affective disorders, 2003, Volume: 76, Issue:1-3 Topics: Adult; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Depressive Disorder; Endpoint Determination; Female; Fluoxetine; Humans; Male; Middle Aged; Nortriptyline; Psychiatric Status Rating Scales; Severity of Illness Index; Social Behavior; Treatment Outcome	2003
Age may affect response to antidepressants with serotonergic and noradrenergic actions. Journal of affective disorders, 2003, Volume: 76, Issue:1-3 Topics: Adolescent; Adult; Age Factors; Aged; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Clomipramine; Depressive Disorder; Double-Blind Method; Female; Fluoxetine; Humans; Male; Middle Aged; Nortriptyline; Treatment Outcome	2003
Mortality and poststroke depression: a placebo-controlled trial of antidepressants. The American journal of psychiatry, 2003, Volume: 160, Issue:10 Topics: Adrenergic Uptake Inhibitors; Aged; Antidepressive Agents; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Depression; Female; Fluoxetine; Humans; Male; Middle Aged; Neurologic Examination; Nortriptyline; Selective Serotonin Reuptake Inhibitors; Stroke; Survival Analysis; Treatment Outcome	2003
Age-dependent antidepressant pharmacogenomics: polymorphisms of the serotonin transporter and G protein beta3 subunit as predictors of response to fluoxetine and nortriptyline. The international journal of neuropsychopharmacology, 2003, Volume: 6, Issue:4 Topics: Adult; Age Factors; Alleles; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Bipolar Disorder; Carrier Proteins; Depressive Disorder, Major; Female; Fluoxetine; Genotype; GTP-Binding Protein beta Subunits; Humans; Male; Membrane Glycoproteins; Membrane Transport Proteins; Nerve Tissue Proteins; Nortriptyline; Personality Assessment; Personality Inventory; Pharmacogenetics; Polymorphism, Genetic; Prognosis; Serotonin Plasma Membrane Transport Proteins; Treatment Outcome	2003
Double-blind comparison of fluoxetine and nortriptyline in the treatment of moderate to severe major depression. Journal of clinical pharmacy and therapeutics, 2003, Volume: 28, Issue:5 Topics: Adult; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Depressive Disorder; Double-Blind Method; Female; Fluoxetine; Humans; Male; Middle Aged; Nortriptyline	2003
Does antidepressant therapy improve cognition in elderly depressed patients? The journals of gerontology. Series A, Biological sciences and medical sciences, 2003, Volume: 58, Issue:12 Topics: Aged; Aged, 80 and over; Antidepressive Agents; Cognition; Cognition Disorders; Confidence Intervals; Depressive Disorder; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Fluoxetine; Follow-Up Studies; Humans; Male; Middle Aged; Neuropsychological Tests; Nortriptyline; Probability; Reference Values; Sertraline; Severity of Illness Index; Single-Blind Method; Statistics, Nonparametric; Treatment Outcome	2003
No evidence of increased adverse drug reactions in cytochrome P450 CYP2D6 poor metabolizers treated with fluoxetine or nortriptyline. Human psychopharmacology, 2004, Volume: 19, Issue:1 Topics: Adolescent; Adult; Antidepressive Agents; Cytochrome P-450 CYP2D6; Depressive Disorder, Major; Female; Fluoxetine; Genotype; Humans; Male; Middle Aged; Mutation; Nortriptyline	2004
Thyroid indices and response to fluoxetine and nortriptyline in major depression. Journal of psychopharmacology (Oxford, England), 2003, Volume: 17, Issue:4 Topics: Adolescent; Adult; Antidepressive Agents; Depressive Disorder; Female; Fluoxetine; Humans; Male; Middle Aged; Nortriptyline; Psychiatric Status Rating Scales; Thyroid Function Tests; Thyroid Hormones; Thyrotropin-Releasing Hormone; Thyroxine	2003
Bipolar II disorder: personality and outcome in two clinical samples. The Australian and New Zealand journal of psychiatry, 2004, Volume: 38, Issue:6 Topics: Adrenergic Uptake Inhibitors; Adult; Bipolar Disorder; Bulimia; Cognitive Behavioral Therapy; Depressive Disorder, Major; Diagnostic and Statistical Manual of Mental Disorders; Female; Fluoxetine; Follow-Up Studies; Humans; Male; Nortriptyline; Personality Disorders; Selective Serotonin Reuptake Inhibitors	2004
Reversed diurnal variation in depression: associations with a differential antidepressant response, tryptophan: large neutral amino acid ratio and serotonin transporter polymorphisms. Psychological medicine, 2005, Volume: 35, Issue:4 Topics: Adult; Affect; Alleles; Amino Acids; Antidepressive Agents; Bipolar Disorder; Circadian Rhythm; Depressive Disorder, Major; Female; Fluoxetine; Gene Frequency; Genotype; Humans; Male; Membrane Glycoproteins; Membrane Transport Proteins; Middle Aged; Nerve Tissue Proteins; Nortriptyline; Polymorphism, Genetic; Prognosis; Promoter Regions, Genetic; Serotonin Plasma Membrane Transport Proteins; Treatment Outcome; Tryptophan	2005
Tryptophan and tyrosine availability and response to antidepressant treatment in major depression. Journal of affective disorders, 2005, Volume: 86, Issue:2-3 Topics: Adrenergic Uptake Inhibitors; Adult; Amino Acids, Neutral; Antidepressive Agents, Tricyclic; Circadian Rhythm; Depressive Disorder, Major; Female; Fluoxetine; Follow-Up Studies; Humans; Hydrocortisone; Male; Nortriptyline; Prolactin; Psychiatric Status Rating Scales; Research Design; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Tryptophan; Tyrosine	2005
Olanzapine/fluoxetine combination for treatment-resistant depression: a controlled study of SSRI and nortriptyline resistance. The Journal of clinical psychiatry, 2005, Volume: 66, Issue:10 Topics: Adult; Antipsychotic Agents; Benzodiazepines; Depressive Disorder, Major; Diagnostic and Statistical Manual of Mental Disorders; Double-Blind Method; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Female; Fluoxetine; Humans; Male; Nortriptyline; Olanzapine; Pilot Projects; Placebos; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Treatment Outcome	2005
Genetic, developmental and personality correlates of self-mutilation in depressed patients. The Australian and New Zealand journal of psychiatry, 2006, Volume: 40, Issue:3 Topics: Adolescent; Adult; Alleles; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Borderline Personality Disorder; Child; Child Abuse; Child Abuse, Sexual; Comorbidity; Depressive Disorder, Major; Female; Fluoxetine; Genetic Predisposition to Disease; Genotype; Glucosyltransferases; Humans; Male; Multivariate Analysis; Nortriptyline; Outcome Assessment, Health Care; Polymorphism, Genetic; Prospective Studies; Risk Factors; Self Mutilation; Statistics as Topic	2006
A comparison of effects of fluoxetine and nortriptyline on the symptoms of major depressive disorder. Journal of clinical psychopharmacology, 2006, Volume: 26, Issue:2 Topics: Adrenergic Uptake Inhibitors; Adult; Depressive Disorder, Major; Female; Fluoxetine; Humans; Iran; Male; Nortriptyline; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors	2006
Aggressive behavior in patients with stroke: association with psychopathology and results of antidepressant treatment on aggression. Archives of physical medicine and rehabilitation, 2006, Volume: 87, Issue:6 Topics: Aged; Aggression; Analysis of Variance; Antidepressive Agents, Tricyclic; Depression; Double-Blind Method; Female; Fluoxetine; Humans; Male; Middle Aged; Nortriptyline; Psychiatric Status Rating Scales; Regression Analysis; Stroke; Stroke Rehabilitation; Treatment Outcome	2006
Effect of antidepressant therapy on executive function after stroke. The British journal of psychiatry : the journal of mental science, 2007, Volume: 190 Topics: Aged; Antidepressive Agents; Cognition Disorders; Double-Blind Method; Female; Fluoxetine; Humans; Male; Nortriptyline; Regression Analysis; Stroke; Treatment Outcome	2007
Risk factors for and correlates of poststroke depression following discontinuation of antidepressants. The Journal of neuropsychiatry and clinical neurosciences, 2007,Fall, Volume: 19, Issue:4 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antidepressive Agents; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Cerebrovascular Circulation; Depressive Disorder; Female; Fluoxetine; Frontal Lobe; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Middle Aged; Nortriptyline; Psychiatric Status Rating Scales; Regression Analysis; Risk Factors; Social Behavior; Stroke; Substance Withdrawal Syndrome; Tomography, X-Ray Computed	2007
Antidepressant treatment is associated with a reduction in suicidal ideation and suicide attempts. Acta psychiatrica Scandinavica, 2008, Volume: 118, Issue:2 Topics: Adolescent; Adult; Aged; Antidepressive Agents; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Depressive Disorder; Female; Fluoxetine; Humans; Male; Middle Aged; Nortriptyline; Prospective Studies; Psychiatric Status Rating Scales; Suicide; Suicide Prevention; Treatment Outcome	2008
Eighteen months of drug treatment for depression: predicting relapse and recovery. Journal of affective disorders, 2009, Volume: 114, Issue:1-3 Topics: Adolescent; Adult; Analysis of Variance; Antidepressive Agents; Depressive Disorder; Dose-Response Relationship, Drug; Female; Fluoxetine; Follow-Up Studies; Humans; Male; Middle Aged; Nortriptyline; Outpatients; Personality Assessment; Personality Disorders; Prospective Studies; Psychiatric Status Rating Scales; Risk Assessment; Schizotypal Personality Disorder; Secondary Prevention; Severity of Illness Index; Time Factors; Treatment Outcome; Young Adult	2009
Orosomucoid influences the response to antidepressants in major depressive disorder. Journal of psychopharmacology (Oxford, England), 2010, Volume: 24, Issue:4 Topics: Adult; Antidepressive Agents; Biomarkers; Depressive Disorder, Major; Female; Fluoxetine; Genotype; Humans; Logistic Models; Male; Medication Adherence; Nortriptyline; Odds Ratio; Orosomucoid; Outpatients; Phenotype; Polymorphism, Genetic; Psychiatric Status Rating Scales; Time Factors; Treatment Outcome; Young Adult	2010
Childhood neglect and abuse as predictors of antidepressant response in adult depression. Depression and anxiety, 2009, Volume: 26, Issue:8 Topics: Adult; Age of Onset; Antidepressive Agents; Child; Child Abuse; Child Abuse, Sexual; Chronic Disease; Comorbidity; Depressive Disorder, Major; Female; Fluoxetine; Humans; Interview, Psychological; Male; Nortriptyline; Object Attachment; Parenting; Prognosis; Risk Factors; Treatment Outcome	2009
Personality disorders improve in patients treated for major depression. Acta psychiatrica Scandinavica, 2010, Volume: 122, Issue:3 Topics: Adult; Antidepressive Agents; Bipolar Disorder; Comorbidity; Depressive Disorder, Major; Dose-Response Relationship, Drug; Female; Fluoxetine; Follow-Up Studies; Humans; Interview, Psychological; Male; Nortriptyline; Personality Assessment; Personality Disorders	2010
Measures of temperament and character are differentially impacted on by depression severity. Journal of affective disorders, 2010, Volume: 126, Issue:1-2 Topics: Adult; Affect; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Cognitive Behavioral Therapy; Depressive Disorder, Major; Female; Fluoxetine; Humans; Male; Nortriptyline; Personality; Personality Assessment; Psychiatric Status Rating Scales; Psychotherapy; Regression Analysis; Severity of Illness Index; Temperament	2010
Effect of antidepressants on the course of disability following stroke. The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry, 2011, Volume: 19, Issue:12 Topics: Activities of Daily Living; Adolescent; Adult; Aged; Aged, 80 and over; Antidepressive Agents; Depressive Disorder; Disability Evaluation; Double-Blind Method; Female; Fluoxetine; Humans; Male; Middle Aged; Models, Statistical; Nortriptyline; Psychiatric Status Rating Scales; Severity of Illness Index; Stroke; Stroke Rehabilitation	2011

Other Studies

79 other study(ies) available for fluoxetine and nortriptyline

Article	Year
2-Substituted tryptamines: agents with selectivity for 5-HT(6) serotonin receptors. Journal of medicinal chemistry, 2000, Mar-09, Volume: 43, Issue:5 Topics: Adenylyl Cyclases; Cell Line; Enzyme Activation; Humans; Methoxydimethyltryptamines; Radioligand Assay; Receptors, Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists; Structure-Activity Relationship; Tryptamines	2000
QSAR model for drug human oral bioavailability. Journal of medicinal chemistry, 2000, Jun-29, Volume: 43, Issue:13 Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship	2000
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling. Current drug discovery technologies, 2004, Volume: 1, Issue:4 Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration	2004
LeuT-desipramine structure reveals how antidepressants block neurotransmitter reuptake. Science (New York, N.Y.), 2007, Sep-07, Volume: 317, Issue:5843 Topics: Amino Acid Sequence; Animals; Antidepressive Agents, Tricyclic; Bacterial Proteins; Binding Sites; Caenorhabditis elegans Proteins; Cell Line; Conserved Sequence; Crystallography, X-Ray; Desipramine; Dopamine; Dopamine Uptake Inhibitors; Drosophila Proteins; Humans; Leucine; Models, Molecular; Molecular Sequence Data; Neurotransmitter Uptake Inhibitors; Norepinephrine; Norepinephrine Plasma Membrane Transport Proteins; Plasma Membrane Neurotransmitter Transport Proteins; Protein Binding; Protein Conformation; Selective Serotonin Reuptake Inhibitors; Sequence Homology, Amino Acid; Serotonin	2007
High-throughput screening of drug-brain tissue binding and in silico prediction for assessment of central nervous system drug delivery. Journal of medicinal chemistry, 2007, Sep-20, Volume: 50, Issue:19 Topics: Animals; Brain; Central Nervous System Agents; Dialysis; Hydrophobic and Hydrophilic Interactions; In Vitro Techniques; Mice; Models, Statistical; Protein Binding; Quantitative Structure-Activity Relationship; Rats	2007
Identification of new functional inhibitors of acid sphingomyelinase using a structure-property-activity relation model. Journal of medicinal chemistry, 2008, Jan-24, Volume: 51, Issue:2 Topics: Algorithms; Animals; Cell Line; Cell Line, Tumor; Chemical Phenomena; Chemistry, Physical; Enzyme Inhibitors; Humans; Hydrogen-Ion Concentration; Molecular Conformation; Quantitative Structure-Activity Relationship; Rats; Sphingomyelin Phosphodiesterase	2008
Relationship between brain tissue partitioning and microemulsion retention factors of CNS drugs. Journal of medicinal chemistry, 2009, Mar-26, Volume: 52, Issue:6 Topics: Brain; Central Nervous System; Chromatography, Liquid; Emulsions; Mass Spectrometry	2009
Gamma-aminobutyric acid amides of nortriptyline and fluoxetine display improved pain suppressing activity. Journal of medicinal chemistry, 2009, May-14, Volume: 52, Issue:9 Topics: Analgesics; Animals; Antidepressive Agents; Anxiety; Behavior, Animal; Fluoxetine; Formaldehyde; gamma-Aminobutyric Acid; Inflammation; Male; Mice; Nortriptyline; Pain; Rats	2009
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species. Chemical research in toxicology, 2010, Volume: 23, Issue:1 Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship	2010
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models. Toxicology mechanisms and methods, 2008, Volume: 18, Issue:2-3 Topics:	2008
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species. Bioorganic & medicinal chemistry, 2010, Mar-15, Volume: 18, Issue:6 Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics	2010
Predicting phospholipidosis using machine learning. Molecular pharmaceutics, 2010, Oct-04, Volume: 7, Issue:5 Topics: Animals; Artificial Intelligence; Databases, Factual; Drug Discovery; Humans; Lipidoses; Models, Biological; Phospholipids; Support Vector Machine	2010
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development. Toxicological sciences : an official journal of the Society of Toxicology, 2010, Volume: 118, Issue:2 Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics	2010
Brain tissue binding of drugs: evaluation and validation of solid supported porcine brain membrane vesicles (TRANSIL) as a novel high-throughput method. Drug metabolism and disposition: the biological fate of chemicals, 2011, Volume: 39, Issue:2 Topics: Absorption; Albumins; Animals; Brain; Brain Chemistry; Cell Membrane; Chromatography, High Pressure Liquid; Drug Evaluation, Preclinical; In Vitro Techniques; Lipids; Male; Microdialysis; Pharmaceutical Preparations; Protein Binding; Rats; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Swine; Tissue Distribution	2011
FDA-approved drug labeling for the study of drug-induced liver injury. Drug discovery today, 2011, Volume: 16, Issue:15-16 Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration	2011
Identifying a selective substrate and inhibitor pair for the evaluation of CYP2J2 activity. Drug metabolism and disposition: the biological fate of chemicals, 2012, Volume: 40, Issue:5 Topics: Amiodarone; Astemizole; Chromatography, High Pressure Liquid; Cytochrome P-450 CYP2J2; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Danazol; Drug Discovery; Drug Interactions; Enzyme Inhibitors; Humans; Hydroxylation; In Vitro Techniques; Methylation; Microsomes, Liver; Models, Biological; Molecular Structure; Substrate Specificity; Tandem Mass Spectrometry; Terfenadine	2012
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development. Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1 Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests	2013
Development of a cell viability assay to assess drug metabolite structure-toxicity relationships. Bioorganic & medicinal chemistry letters, 2016, 08-15, Volume: 26, Issue:16 Topics: Adenosine Triphosphate; Benzbromarone; Cell Line; Cell Survival; Chromans; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Humans; Pharmaceutical Preparations; Thiazolidinediones; Troglitazone	2016
Depression of REM sleep in cats by nisoxetine, a potential antidepressant drug. Psychopharmacology communications, 1976, Volume: 2, Issue:3 Topics: Animals; Cats; Depression, Chemical; Drug Interactions; Fluoxetine; Levodopa; Male; Nortriptyline; Phenyl Ethers; Propylamines; Serotonin; Sleep, REM; Time Factors	1976
Combination treatment with noradrenalin and serotonin reuptake inhibitors in resistant depression. The British journal of psychiatry : the journal of mental science, 1992, Volume: 161 Topics: 1-Naphthylamine; Adult; Aged; Aged, 80 and over; Depressive Disorder; Drug Therapy, Combination; Female; Fluoxetine; Humans; Lithium; Male; Middle Aged; Nortriptyline; Receptors, Adrenergic; Receptors, Serotonin; Recurrence; Retrospective Studies; Selective Serotonin Reuptake Inhibitors; Sertraline	1992
Single-dose fluoxetine in management of premenstrual syndrome. The Journal of clinical psychiatry, 1992, Volume: 53, Issue:6 Topics: Adult; Depressive Disorder; Dose-Response Relationship, Drug; Female; Fluoxetine; Humans; Nortriptyline; Premenstrual Syndrome	1992
Extremely long plasma half-life of amitriptyline in a woman with the cytochrome P450IID6 29/29-kilobase wild-type allele--a slowly reversible interaction with fluoxetine. Therapeutic drug monitoring, 1991, Volume: 13, Issue:6 Topics: Alleles; Amitriptyline; Chromatography, High Pressure Liquid; Cytochrome P-450 Enzyme System; Debrisoquin; Depression; Drug Interactions; Female; Fluoxetine; Fluvoxamine; Half-Life; Humans; Middle Aged; Nortriptyline; Phenotype; Spectrophotometry, Ultraviolet	1991
Treatment choice after one antidepressant fails: a survey of northeastern psychiatrists. The Journal of clinical psychiatry, 1991, Volume: 52, Issue:9 Topics: Antidepressive Agents; Attitude of Health Personnel; Bupropion; Decision Making; Depressive Disorder; Drug Administration Schedule; Drug Therapy, Combination; Electroconvulsive Therapy; Fluoxetine; Humans; Lithium; Nortriptyline; Propiophenones; Psychiatry; Triiodothyronine	1991
Recent fluoxetine treatment and complications of tricyclic therapy. The American journal of psychiatry, 1991, Volume: 148, Issue:11 Topics: Depressive Disorder; Drug Administration Schedule; Drug Synergism; Drug Therapy, Combination; Female; Fluoxetine; Humans; Middle Aged; Nortriptyline; Triiodothyronine	1991
Elevated tricyclic antidepressant plasma concentrations associated with fluoxetine: two case reports. The Journal of neuropsychiatry and clinical neurosciences, 1990,Fall, Volume: 2, Issue:4 Topics: Adult; Depressive Disorder; Desipramine; Drug Therapy, Combination; Female; Fluoxetine; Humans; Male; Metabolic Clearance Rate; Nortriptyline	1990
Precaution with titrating nortriptyline after the use of fluoxetine. DICP : the annals of pharmacotherapy, 1990, Volume: 24, Issue:10 Topics: Delirium; Fluoxetine; Humans; Male; Middle Aged; Nortriptyline; Psychoses, Substance-Induced	1990
Increased plasma nortriptyline concentration in a patient cotreated with fluoxetine. The Journal of clinical psychiatry, 1990, Volume: 51, Issue:1 Topics: Depressive Disorder; Drug Interactions; Drug Therapy, Combination; Dyspnea; Fatigue; Fluoxetine; Humans; Male; Middle Aged; Nortriptyline; Physical Exertion	1990
Drug-drug interactions of fluoxetine with tricyclics. Psychosomatics, 1990,Summer, Volume: 31, Issue:3 Topics: Depressive Disorder; Desipramine; Drug Synergism; Drug Therapy, Combination; Fluoxetine; Humans; Metabolic Clearance Rate; Nortriptyline	1990
Radiologic correlates of antidepressant-induced delirium: the possible significance of basal-ganglia lesions. The Journal of neuropsychiatry and clinical neurosciences, 1989,Spring, Volume: 1, Issue:2 Topics: Aged; Aged, 80 and over; Amitriptyline; Antidepressive Agents; Basal Ganglia; Basal Ganglia Diseases; Delirium; Depressive Disorder; Female; Fluoxetine; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Nortriptyline; Risk Factors; Trazodone	1989
Fluoxetine and nortriptyline combination therapy. The American journal of psychiatry, 1989, Volume: 146, Issue:12 Topics: Adult; Depressive Disorder; Drug Interactions; Drug Therapy, Combination; Fluoxetine; Humans; Male; Nortriptyline	1989
Premenstrual syndrome treatments. The Journal of clinical psychiatry, 1989, Volume: 50, Issue:10 Topics: Adult; Depressive Disorder; Female; Fluoxetine; Humans; Nortriptyline; Premenstrual Syndrome	1989
Regulation of high- and low-affinity [3H]imipramine recognition sites in rat brain by chronic treatment with antidepressants. European journal of pharmacology, 1987, Jun-19, Volume: 138, Issue:2 Topics: Animals; Antidepressive Agents; Binding, Competitive; Biogenic Amines; Brain; Carrier Proteins; Fluoxetine; In Vitro Techniques; Iprindole; Kinetics; Male; Maprotiline; Nortriptyline; Phenelzine; Rats; Rats, Inbred Strains; Receptors, Drug; Receptors, Neurotransmitter; Serotonin; Synaptosomes	1987
Screening of antiserotoninergic drugs with the genetically dystrophic chicken. Archives of neurology, 1980, Volume: 37, Issue:9 Topics: Animals; Aspartate Aminotransferases; Chickens; Creatine Kinase; Drug Evaluation, Preclinical; Ergonovine; Female; Fenclonine; Fluoxetine; L-Lactate Dehydrogenase; Male; Methiothepin; Methysergide; Muscular Dystrophy, Animal; Nortriptyline; Penicillamine; Serotonin Antagonists	1980
A prospective study of lithium augmentation in antidepressant-resistant geriatric depression. Journal of clinical psychopharmacology, 1994, Volume: 14, Issue:5 Topics: Aged; Aged, 80 and over; Antidepressive Agents; Depressive Disorder; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Fluoxetine; Humans; Lithium Carbonate; Male; Mental Status Schedule; Middle Aged; Nortriptyline; Phenelzine; Prospective Studies	1994
Chlorimipramine and nortriptyline but not fluoxetine and fluvoxamine inhibit human polymorphonuclear cell chemotaxis in vitro. General pharmacology, 1994, Volume: 25, Issue:3 Topics: Antidepressive Agents; Chemotaxis, Leukocyte; Clomipramine; Fluoxetine; Fluvoxamine; Humans; In Vitro Techniques; Neutrophils; Nortriptyline	1994
Concurrent liquid chromatographic measurement of fluoxetine, amitriptyline, imipramine, and their active metabolites norfluoxetine, nortriptyline, and desipramine in plasma. Therapeutic drug monitoring, 1993, Volume: 15, Issue:4 Topics: Amitriptyline; Antidepressive Agents, Tricyclic; Chromatography, Liquid; Desipramine; Fluoxetine; Humans; Imipramine; Indicators and Reagents; Nortriptyline; Spectrophotometry, Ultraviolet	1993
Fluoxetine (Prozac) The Medical journal of Australia, 1993, Oct-04, Volume: 159, Issue:7 Topics: Aged; Drug Interactions; Drug Therapy, Combination; Female; Fluoxetine; Humans; Nortriptyline	1993
[Toxic tricyclic drug plasma level caused by fluoxetine]. Psychiatrische Praxis, 1995, Volume: 22, Issue:6 Topics: Amitriptyline; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Depressive Disorder; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Fluoxetine; Heart Block; Humans; Metabolic Clearance Rate; Middle Aged; Nortriptyline; Recurrence	1995
The effect of sequential antidepressant treatment on geriatric depression. Journal of affective disorders, 1996, Jan-22, Volume: 36, Issue:3-4 Topics: Aged; Aged, 80 and over; Antidepressive Agents; Clinical Protocols; Combined Modality Therapy; Dementia; Depressive Disorder; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Electroconvulsive Therapy; Female; Fluoxetine; Humans; Lithium Carbonate; Male; Middle Aged; Nortriptyline; Personality Inventory; Phenelzine; Prospective Studies; Treatment Outcome	1996
Alterations in plasma dipeptidyl peptidase IV enzyme activity in depression and schizophrenia: effects of antidepressants and antipsychotic drugs. Acta psychiatrica Scandinavica, 1996, Volume: 93, Issue:1 Topics: Adult; Antidepressive Agents; Antipsychotic Agents; Bipolar Disorder; Depressive Disorder; Dipeptidyl Peptidase 4; Dose-Response Relationship, Drug; Female; Fluoxetine; Haloperidol; Humans; Hydrocortisone; Imipramine; Male; Middle Aged; Nortriptyline; Perphenazine; Psychiatric Status Rating Scales; Schizophrenia; Schizophrenic Psychology	1996
Psychiatrists' responses to failure of maintenance therapy with antidepressants. Psychiatric services (Washington, D.C.), 1997, Volume: 48, Issue:6 Topics: 1-Naphthylamine; Adult; Antidepressive Agents; Attitude of Health Personnel; Depressive Disorder; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Fluoxetine; Humans; Lithium; Male; Nortriptyline; Recurrence; Sertraline; Treatment Failure	1997
Nortriptyline for the treatment of depression in progressive supranuclear palsy. Journal of the American Geriatrics Society, 1997, Volume: 45, Issue:8 Topics: Adrenergic Uptake Inhibitors; Aged; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Depression; Dopamine Agents; Female; Fluoxetine; Humans; Levodopa; Nortriptyline; Remission Induction; Supranuclear Palsy, Progressive	1997
Venlafaxine-fluoxetine-nortriptyline interaction. Journal of psychiatry & neuroscience : JPN, 1997, Volume: 22, Issue:4 Topics: Aged; Antidepressive Agents; Cyclohexanols; Depressive Disorder; Drug Interactions; Drug Therapy, Combination; Female; Fluoxetine; Humans; Nortriptyline; Venlafaxine Hydrochloride	1997
Cardiovascular effects of fluoxetine in depressed patients with heart disease. The American journal of psychiatry, 1998, Volume: 155, Issue:5 Topics: Adult; Aged; Antidepressive Agents, Tricyclic; Blood Pressure; Comorbidity; Depressive Disorder; Drug Administration Schedule; Electrocardiography; Female; Fluoxetine; Heart Diseases; Heart Rate; Hemodynamics; Humans; Hypotension, Orthostatic; Male; Nortriptyline; Selective Serotonin Reuptake Inhibitors; Stroke Volume	1998
Effect of some antidepressants on glycaemia and insulin levels of normoglycaemic and alloxan-induced hyperglycaemic mice. The Journal of pharmacy and pharmacology, 1999, Volume: 51, Issue:6 Topics: Alloxan; Animals; Antidepressive Agents; Blood Glucose; Female; Fluoxetine; Hyperglycemia; Insulin; Male; Mice; Nortriptyline; Sertraline	1999
Effect of fluoxetine on contractile activity of pregnant rat uterine rings. American journal of obstetrics and gynecology, 2000, Volume: 182, Issue:2 Topics: Adrenergic Uptake Inhibitors; Animals; Antidepressive Agents, Tricyclic; Dose-Response Relationship, Drug; Female; Fluoxetine; Imipramine; Isometric Contraction; Nortriptyline; Pregnancy; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Serotonin; Uterine Contraction; Uterus	2000
Maintenance treatment for recurrent depression in late life. A four-year outcome study. The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry, 2000,Spring, Volume: 8, Issue:2 Topics: Aged; Antidepressive Agents; Combined Modality Therapy; Depressive Disorder, Major; Drug Therapy, Combination; Electroconvulsive Therapy; Female; Fluoxetine; Follow-Up Studies; Humans; Lithium Carbonate; Long-Term Care; Male; Middle Aged; Nortriptyline; Phenelzine; Recurrence; Treatment Outcome	2000
Antidepressant-induced regulation of 5-HT(1b) mRNA in rat dorsal raphe nucleus reverses rapidly after drug discontinuation. Journal of neuroscience research, 2000, Jul-01, Volume: 61, Issue:1 Topics: Animals; Antidepressive Agents; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Autoreceptors; Fluoxetine; Gene Expression; In Situ Hybridization; Male; Nortriptyline; Paroxetine; Raphe Nuclei; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT1B; Receptors, Serotonin; RNA, Messenger; Sertraline	2000
Electrophysiologic analysis of antidepressant drug effects on the GABA(A) receptor complex based upon antagonist-induced encephalographic power spectrum changes. Neuropsychobiology, 2000, Volume: 42, Issue:3 Topics: Animals; Antidepressive Agents; Desipramine; Electroencephalography; Fluoxetine; Fourier Analysis; GABA Antagonists; Hippocampus; Imipramine; Male; Nortriptyline; Pentylenetetrazole; Rats; Rats, Wistar; Trazodone	2000
Poststroke depression. The American journal of psychiatry, 2001, Volume: 158, Issue:4 Topics: Aged; Antidepressive Agents, Tricyclic; Depressive Disorder; Fluoxetine; Humans; Middle Aged; Nortriptyline; Randomized Controlled Trials as Topic; Research Design; Selective Serotonin Reuptake Inhibitors; Stroke; Weight Gain	2001
Comparison of noradrenergic and serotonergic antidepressants in reducing immobility time in the tail suspension test. Japanese journal of pharmacology, 2001, Volume: 85, Issue:3 Topics: Adrenergic Uptake Inhibitors; Animals; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Desipramine; Fluoxetine; Fluvoxamine; Male; Models, Animal; Nortriptyline; Rats; Rats, Inbred Strains; Selective Serotonin Reuptake Inhibitors; Synaptic Transmission; Tail	2001
Melancholia: definitions, risk factors, personality, neuroendocrine markers and differential antidepressant response. The Australian and New Zealand journal of psychiatry, 2002, Volume: 36, Issue:3 Topics: Age Factors; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Depressive Disorder; Fluoxetine; Humans; Nortriptyline; Personality; Psychiatric Status Rating Scales; Psychomotor Disorders; Reproducibility of Results; Risk Factors; Sex Factors	2002
Those high-cholesterol blues. Harvard health letter, 2003, Volume: 28, Issue:11 Topics: Antidepressive Agents; Cholesterol; Depression; Fluoxetine; Humans; Hypercholesterolemia; Nortriptyline	2003
Mechanism-based inhibition of CYP activities in rat liver by fluoxetine and structurally similar alkylamines. Xenobiotica; the fate of foreign compounds in biological systems, 2003, Volume: 33, Issue:10 Topics: Adrenergic Uptake Inhibitors; Amines; Animals; Aryl Hydrocarbon Hydroxylases; Binding Sites; Cytochrome P450 Family 2; Desipramine; Diffusion; Dose-Response Relationship, Drug; Enzyme Inhibitors; Fluoxetine; Heme; Hydroxylation; Inhibitory Concentration 50; Kinetics; Liver; Male; Microsomes, Liver; Models, Chemical; NADP; Nortriptyline; Oxygen; Protein Binding; Rats; Rats, Wistar; Selective Serotonin Reuptake Inhibitors; Steroid 16-alpha-Hydroxylase; Steroids; Time Factors	2003
Atypical depression, atypical temperament and a differential antidepressant response to fluoxetine and nortriptyline. Depression and anxiety, 2004, Volume: 19, Issue:3 Topics: Adult; Age Factors; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Depressive Disorder; Female; Fluoxetine; Humans; Male; Nortriptyline; Psychiatric Status Rating Scales; Sex Factors; Temperament; Treatment Outcome	2004
Mortality and poststroke depression. The American journal of psychiatry, 2004, Volume: 161, Issue:8 Topics: Antidepressive Agents; Brain-Derived Neurotrophic Factor; Comorbidity; Depressive Disorder; Fluoxetine; Hippocampus; Humans; Neuronal Plasticity; Nortriptyline; Research Design; Stroke; Survival Analysis	2004
Re: no evidence of increased adverse drug reactions in cytochrome P450 CYP2D6 poor metabolizers treated with fluoxetine or nortriptyline. Human psychopharmacology, 2005, Volume: 20, Issue:1 Topics: Antidepressive Agents; Cytochrome P-450 CYP2D6; Dose-Response Relationship, Drug; Fluoxetine; Humans; Hypertension; Metabolic Clearance Rate; Nortriptyline; Polymorphism, Genetic	2005
Biphasic effects of losartan potassium on immobility in mice. Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan, 2005, Volume: 125, Issue:8 Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Antidepressive Agents; Dose-Response Relationship, Drug; Drug Synergism; Fluoxetine; Freezing Reaction, Cataleptic; Losartan; Male; Mice; Mice, Inbred Strains; Nortriptyline; Receptor, Angiotensin, Type 2; Reserpine; Swimming	2005
Determining the duration of antidepressant treatment: application of signal detection methodology and the need for duration adaptive designs (DAD). Biological psychiatry, 2006, Mar-15, Volume: 59, Issue:6 Topics: Antidepressive Agents, Second-Generation; Depressive Disorder, Major; Dose-Response Relationship, Drug; Drug Administration Schedule; Fluoxetine; Follow-Up Studies; Humans; Nortriptyline; Personality Assessment; Probability; Psychometrics; Randomized Controlled Trials as Topic; Retrospective Studies; Sertraline; Signal Detection, Psychological	2006
Monoamine transporter gene polymorphisms and antidepressant response in koreans with late-life depression. JAMA, 2006, Oct-04, Volume: 296, Issue:13 Topics: Adult; Aged; Antidepressive Agents; Asian People; Depressive Disorder, Major; Female; Fluoxetine; Humans; Korea; Male; Middle Aged; Norepinephrine; Norepinephrine Plasma Membrane Transport Proteins; Nortriptyline; Polymorphism, Genetic; Promoter Regions, Genetic; Selective Serotonin Reuptake Inhibitors; Serotonin Plasma Membrane Transport Proteins; Sertraline	2006
Comparative metabolic capabilities and inhibitory profiles of CYP2D6.1, CYP2D6.10, and CYP2D6.17. Drug metabolism and disposition: the biological fate of chemicals, 2007, Volume: 35, Issue:8 Topics: Atomoxetine Hydrochloride; Cocaine; Codeine; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP2D6 Inhibitors; Debrisoquin; Dextromethorphan; Enzyme Inhibitors; Ethanolamines; Fluoxetine; Humans; Hydroxylation; Imipramine; Kinetics; Microsomes; Molecular Structure; Nortriptyline; Polymorphism, Single Nucleotide; Propylamines; Quinidine; Recombinant Proteins; Thioridazine; Tramadol	2007
Fluoxetine and nortriptyline affect NTPDase and 5'-nucleotidase activities in rat blood serum. Life sciences, 2007, Sep-22, Volume: 81, Issue:15 Topics: 5'-Nucleotidase; Animals; Antidepressive Agents; Blood Coagulation; Dose-Response Relationship, Drug; Fluoxetine; Male; Nortriptyline; Nucleoside-Triphosphatase; Rats; Rats, Wistar	2007
Ecto-nucleotidase pathway is altered by different treatments with fluoxetine and nortriptyline. European journal of pharmacology, 2008, Mar-31, Volume: 583, Issue:1 Topics: Adenosine; Adenosine Triphosphatases; Adenosine Triphosphate; Animals; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Cerebral Cortex; Extracellular Space; Fluoxetine; Hippocampus; Isoenzymes; Male; Norepinephrine; Nortriptyline; Rats; Rats, Wistar; Reverse Transcriptase Polymerase Chain Reaction; Serotonin; Signal Transduction; Synaptosomes	2008
The inhibition of human neutrophil phagocytosis and oxidative burst by tricyclic antidepressants. Anesthesia and analgesia, 2008, Volume: 107, Issue:4 Topics: Amitriptyline; Anesthetics, Local; Antidepressive Agents, Tricyclic; Fluoxetine; Humans; Neutrophils; Nortriptyline; Phagocytosis; Respiratory Burst; Selective Serotonin Reuptake Inhibitors; Staphylococcus aureus	2008
Evaluation of risk factors for elevated tricyclic antidepressant plasma concentrations. Pharmacoepidemiology and drug safety, 2009, Volume: 18, Issue:3 Topics: Amitriptyline; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Bupropion; Case-Control Studies; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP2D6 Inhibitors; Dose-Response Relationship, Drug; Drug Interactions; Drug Monitoring; Drug Therapy, Combination; Female; Fluoxetine; Humans; Male; Middle Aged; Nortriptyline; Paroxetine; Risk Factors; Selective Serotonin Reuptake Inhibitors; Sex Factors	2009
Mutational and in silico analyses for antidepressant block of astroglial inward-rectifier Kir4.1 channel. Molecular pharmacology, 2009, Volume: 75, Issue:6 Topics: Animals; Antidepressive Agents; Astrocytes; Binding Sites; Cell Line; Female; Fluoxetine; Humans; Hydrogen Bonding; In Vitro Techniques; Ligands; Models, Molecular; Mutagenesis, Site-Directed; Mutation; Nortriptyline; Oocytes; Patch-Clamp Techniques; Potassium Channels, Inwardly Rectifying; Protein Conformation; Quantitative Structure-Activity Relationship; Rats; Xenopus laevis	2009
An integrated analysis of olanzapine/fluoxetine combination in clinical trials of treatment-resistant depression. The Journal of clinical psychiatry, 2009, Volume: 70, Issue:3 Topics: Adult; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Benzodiazepines; Cyclohexanols; Depressive Disorder, Major; Double-Blind Method; Drug Resistance; Drug Therapy, Combination; Female; Fluoxetine; Humans; Male; Middle Aged; Nortriptyline; Olanzapine; Personality Inventory; Psychometrics; Randomized Controlled Trials as Topic; Treatment Outcome; Venlafaxine Hydrochloride	2009
A polymorphism of the GTP-cyclohydrolase I feedback regulator gene alters transcriptional activity and may affect response to SSRI antidepressants. The pharmacogenomics journal, 2011, Volume: 11, Issue:3 Topics: Adult; Antidepressive Agents; Biopterins; Clinical Trials as Topic; Female; Fluoxetine; Genetic Association Studies; Haplotypes; Humans; Intracellular Signaling Peptides and Proteins; Male; Mood Disorders; Nortriptyline; Polymorphism, Single Nucleotide; Promoter Regions, Genetic; Selective Serotonin Reuptake Inhibitors; Serotonin; Transcriptional Activation	2011
Mother-infant antidepressant concentrations, maternal depression, and perinatal events. The Journal of clinical psychiatry, 2011, Volume: 72, Issue:7 Topics: Adult; Antidepressive Agents; Antidepressive Agents, Tricyclic; Depressive Disorder, Major; Dose-Response Relationship, Drug; Female; Fetal Blood; Fluoxetine; Humans; Infant, Newborn; Maternal-Fetal Exchange; Nortriptyline; Obstetric Labor, Premature; Personality Inventory; Pregnancy; Pregnancy Outcome; Prenatal Exposure Delayed Effects; Prospective Studies; Psychometrics; Risk Factors; Selective Serotonin Reuptake Inhibitors	2011
Pharmacophore modeling for hERG channel facilitation. Biochemical and biophysical research communications, 2012, Feb-03, Volume: 418, Issue:1 Topics: Animals; Atenolol; Chlorpheniramine; ERG1 Potassium Channel; Ether-A-Go-Go Potassium Channels; Fluoxetine; Haloperidol; Humans; Hydrophobic and Hydrophilic Interactions; Imipramine; Metoprolol; Nortriptyline; Potassium Channel Blockers; Promethazine; Propranolol; Quantitative Structure-Activity Relationship; Sotalol; Terfenadine; Verapamil; Xenopus laevis	2012
Antidepressants differentially modify the extinction of an aversive memory task in female rats. Progress in neuro-psychopharmacology & biological psychiatry, 2012, Apr-27, Volume: 37, Issue:1 Topics: Animals; Antidepressive Agents; Anxiety; Avoidance Learning; Extinction, Psychological; Female; Fluoxetine; Maze Learning; Memory; Mianserin; Mirtazapine; Nortriptyline; Psychomotor Performance; Rats; Rats, Wistar	2012
Novel CYP2D6 and CYP2C19 variants identified in a patient with adverse reactions towards venlafaxine monotherapy and dual therapy with nortriptyline and fluoxetine. Pharmacogenetics and genomics, 2013, Volume: 23, Issue:9 Topics: Antidepressive Agents; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Aryl Hydrocarbon Hydroxylases; Base Sequence; Cyclohexanols; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP2D6; Drug Administration Schedule; Drug Therapy, Combination; Female; Fluoxetine; Haplotypes; Humans; Molecular Sequence Data; Nortriptyline; Polymorphism, Genetic; Sequence Analysis, DNA; Venlafaxine Hydrochloride; Young Adult	2013
Dose equivalents of antidepressants: Evidence-based recommendations from randomized controlled trials. Journal of affective disorders, 2015, Jul-15, Volume: 180 Topics: Adult; Amitriptyline; Antidepressive Agents; Bupropion; Citalopram; Depressive Disorder, Major; Dose-Response Relationship, Drug; Double-Blind Method; Evidence-Based Medicine; Female; Fluoxetine; Fluvoxamine; Humans; Male; Middle Aged; Moclobemide; Nortriptyline; Paroxetine; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome	2015
Antidepressant activity of nociceptin/orphanin FQ receptor antagonists in the mouse learned helplessness. Psychopharmacology, 2016, Volume: 233, Issue:13 Topics: Animals; Antidepressive Agents; Behavior, Animal; Cycloheptanes; Depressive Disorder; Disease Models, Animal; Fluoxetine; Helplessness, Learned; Male; Mice; Narcotic Antagonists; Nociceptin; Nociceptin Receptor; Nortriptyline; Opioid Peptides; Piperidines; Receptors, Opioid; Signal Transduction	2016
Prevention of unpredictable chronic stress-related phenomena in zebrafish exposed to bromazepam, fluoxetine and nortriptyline. Psychopharmacology, 2016, Volume: 233, Issue:21-22 Topics: Animals; Anti-Anxiety Agents; Antidepressive Agents; Behavior, Animal; Bromazepam; Cyclooxygenase 2; Disease Models, Animal; Female; Fluoxetine; Hydrocortisone; Interleukin-10; Interleukin-6; Male; Neurosecretory Systems; Nortriptyline; Stress, Psychological; Tumor Necrosis Factor-alpha; Zebrafish	2016
Monoaminergic neurotransmission is mediating the antidepressant-like effects of Passiflora edulis Sims fo. edulis. Neuroscience letters, 2017, Nov-01, Volume: 660 Topics: Acetates; Animals; Antidepressive Agents; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Behavior, Animal; Benzylamines; Biogenic Monoamines; Butanols; Catecholamines; Depression; Dopamine Antagonists; Fluoxetine; Male; Mice; Nortriptyline; Passiflora; Plant Extracts; Sulpiride; Synaptic Transmission	2017
NOP agonists prevent the antidepressant-like effects of nortriptyline and fluoxetine but not R-ketamine. Psychopharmacology, 2018, Volume: 235, Issue:11 Topics: Anesthetics, Dissociative; Animals; Antidepressive Agents; Brain; Emotions; Fluoxetine; Helplessness, Learned; Imidazoles; Ketamine; Male; Mice; Nociceptin; Nortriptyline; Opioid Peptides; Receptors, Opioid; Spiro Compounds; Swimming	2018
Experimental and Clinical Pharmacokinetics of Fluoxetine and Amitriptyline: Comparative Analysis and Possible Methods of Extrapolation. Bulletin of experimental biology and medicine, 2019, Volume: 167, Issue:3 Topics: Administration, Oral; Amitriptyline; Animals; Biological Availability; Dogs; Female; Fluoxetine; Humans; Male; Nortriptyline	2019
Storage of urine specimens in point of care (POC) urine drug testing cups reduces concentrations of many drugs. Clinica chimica acta; international journal of clinical chemistry, 2019, Volume: 499 Topics: Amitriptyline; Chromatography, Liquid; Drug Storage; Fentanyl; Flunitrazepam; Fluoxetine; Humans; Mass Spectrometry; Nortriptyline; Paroxetine; Point-of-Care Testing; Sertraline	2019